Free tool
FAERS Monitor: Prezcobix
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205395 or its brand name (Prezcobix, Cobicistat, Darunavir Ethanolate). Reports on generic versions are filed under their own applications.
Reports
1,762
Serious
1,152
65% of reports
Hospitalization
397
Death reported
136
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain440
- emotional distress426
- anxiety404
- anhedonia377
- chronic kidney disease256
- osteoporosis181
- bone density decreased170
- renal failure170
- depression147
- economic problem138
- fatigue135
- acute kidney injury131
- osteopenia111
- renal impairment104
- blood creatinine increased95
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2013 | 1 |
| 2015 | 69 |
| 2016 | 111 |
| 2017 | 194 |
| 2018 | 211 |
| 2019 | 289 |
| 2020 | 284 |
| 2021 | 170 |
| 2022 | 123 |
| 2023 | 113 |
| 2024 | 97 |
| 2025 | 65 |
| 2026 | 35 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,397 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anhedoniaSignal | 377 | 173.7 | 158.7 | 63,720 |
| economic problemSignal | 138 | 109.7 | 93.4 | 14,627 |
| osteopeniaSignal | 111 | 88.0 | 73.4 | 9,393 |
| bone density decreasedSignal | 170 | 65.1 | 56.4 | 10,626 |
| osteoporosisSignal | 181 | 52.8 | 45.9 | 9,117 |
| emotional distressSignal | 426 | 42.1 | 38.8 | 17,110 |
| chronic kidney diseaseSignal | 256 | 40.4 | 36.0 | 9,787 |
| blood creatinine increasedSignal | 95 | 17.4 | 14.3 | 1,454 |
| anxietySignal | 404 | 17.0 | 15.6 | 6,129 |
| renal failureSignal | 170 | 15.3 | 13.3 | 2,269 |
| renal impairmentSignal | 104 | 14.8 | 12.3 | 1,328 |
| acute kidney injurySignal | 131 | 10.2 | 8.7 | 1,088 |
| painSignal | 440 | 8.6 | 7.9 | 3,014 |
| depressionSignal | 147 | 7.7 | 6.6 | 861 |
| fatigueSignal | 135 | 2.1 | 1.8 | 76 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.